2,274
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Costs of biomarker testing among patients with metastatic lung or thyroid cancer in the USA: a real-world commercial claims database study

ORCID Icon, , , &
Pages 43-50 | Received 13 Sep 2022, Accepted 30 Nov 2022, Published online: 28 Dec 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.